Table 2.
Characteristics of included studies and their frequencies
| n (%) | Included studies | |
|---|---|---|
| Publication year | ||
| 2000–2010 | 9% | Elkis-Abuhoff D et al.(2009) |
| 2011–2022 | 73% | Yaoli Li et al.(2017),Shufen Zhao et al.(2017),Shufen Zhao et al.(2019),Gürcan M and Atay Turan S(2020),Gürcan M and Atay Turan S(2021),Yakar H K et al.(2021),Lili Sun et al.(2021),Lingyu Su et al.(2022) |
| 2023 | 18% | Moharamkhani M et al.(2023),Akbulak F and Can G(2023) |
| Research design | ||
| Qualitative studies | 18% | Elkis-Abuhoff D et al.(2009),Gürcan M and Atay Turan S(2020) |
| Quantitative studies | ||
| Controlled trial | 55% | Yaoli Li et al.(2017),Shufen Zhao et al.(2017),Shufen Zhao et al.(2019),Gürcan M and Atay Turan S(2020),Gürcan M and Atay Turan S(2021),Lili Sun et al.(2021),Lingyu Su et al.(2022) |
| Type of experimental studies | 27% | Yakar H K et al.(2021),Moharamkhani M et al.(2023),Akbulak F and Can G(2023) |
| Country of origin | ||
| China | 46% | Yaoli Li et al.(2017),Shufen Zhao et al.(2017),Shufen Zhao et al.(2019),Lili Sun et al.(2021),Lingyu Su et al.(2022) |
| Turkey | 36% | Gürcan M and Atay Turan S(2020),Gürcan M and Atay Turan S(2021),Yakar H K et al.(2021),Akbulak F and Can G(2023) |
| United States Of America | 9% | Elkis-Abuhoff D et al.(2009) |
| Iran | 9% | Moharamkhani M et al.(2023) |